A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?
ABBVIE INC. · PHARMACEUTICAL PREPARATIONS · Now $212.93
+4.7% in 7d after detection
Post-detection moves
1h
—
1d
+2.5%
3d
+3.9%
7d
+4.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS